Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Therapy Management and Outcomes in Newly Diagnosed Unfit AML Patients Receiving Venetoclax + HMA - Insights from a Prospective Real-World Study in Switzerland and Austria

Thomas Pabst, Thomas Lehmann, Petra Pichler, Sigrid Machherndl-Spandl, Michael Gregor, Jeroen S. Goede, Sabine Gerull, Daniel Maria Mayer, Jean-François Lambert, Catherine Germanier, Georg Stüssi

Blood (2024) 144 (Supplement 1): 2413.

https://doi.org/10.1182/blood-2024-193999

Published: 2024

Journal Articles

A National Platform and Scoring System Allocates CAR-T Treatment Slots for Multiple Myeloma to Patients with High Likelihood of Complete Remission

Christoph Driessen, Katharina Baur, Dominik Heim, Sabine Gerull, Christoph Renner, Anne Cairoli, Thomas Pabst, Joerg Halter, Michael Gregor, Nicole Graf, Nino Fejzibegovic, Nathan Wolfensberger, Federico Simonetta, Martin Fehr, Esteban Ciliberti, Rouven Müller, Barbara Jeker

Blood (2023) 142 (Supplement 1): 4701.

https://doi.org/10.1182/blood-2023-182628

Published: 2023

Journal Articles

Impact of Amotosalen/UVA Pathogen Inactivated Platelet Components on Outcomes after Allogeneic Hematopoetic Stem Cell Transplantation: A Single Center Analysis

Andreas S. Buser, MD, Laura Infanti, MD, Andreas Holbro, MD, Joerg Halter, MD, Sabine Gerull, MD, Dominik Heim, MD, Michael Medinger, MD, Dimitrios A. Tsakiris, MD, Johannes Irsch, PhD, Jin-Sying Lin, PhD, Richard J. Benjamin, MD, Laurence Corash, MD, Jakob R. Passweg, MD

Blood (2019) 134 (Supplement_1): 1167.

https://doi.org/10.1182/blood-2019-122330

Published: 2019

Journal Articles

Red Blood Cell Allo-Antibodies after Allogeneic Hematopoietic Stem Cell Transplantation

Astrid Beerlage, MD, Joerg Halter, MD, Sabine Gerull, MD, Michael Medinger, MD, Tanja Ruefli, Georg Stussi, MD, Dominik Heim, MD, Beatrice Drexler, MD, Laura Infanti, MD, Andreas Holbro, MD, Jakob R. Passweg, MDMS, Andreas S. Buser, MD

Blood (2018) 132 (Supplement 1): 2551.

https://doi.org/10.1182/blood-2018-99-116237

Published: 2018

Journal Articles

Evaluation Of The Pre-Transplantation Workup Before Allogeneic Transplantation and Reasons For Delaying Or Cancelling Transplant

Sabine Gerull, MD, Andreas S Buser, MD, Christoph Bucher, MD, Dominik Heim, MD, Michael Medinger, MD, Jakob Passweg, MD, Martin Stern, MD

Blood (2013) 122 (21): 5456.

https://doi.org/10.1182/blood.V122.21.5456.5456

Published: 2013

Journal Articles

Allogeneic Transplantation for Multiple Myeloma – the Swiss Experience

Sabine Gerull, MD, Yves Chalandon, MD, Markus G Manz, MD, Bilal Mohty, MD, Urs Schanz, MD, Martin Stern, MD, Georg Stussi, MD, Jakob R. Passweg, MD

Blood (2011) 118 (21): 3112.

https://doi.org/10.1182/blood.V118.21.3112.3112

Published: 2011

Journal Articles

Prognostic Impact of Different Iron Parameters In Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Godwin Nosakhare Bazuave, MD, Andreas S. Buser, MD, Sabine Gerull, MD, André Tichelli, MD, Martin Stern, MD

Blood (2010) 116 (21): 168.

https://doi.org/10.1182/blood.V116.21.168.168

Published: 2010

Journal Articles

Cyclosporine Levels and Rate of Graft Rejection Following Reduced Intensity Conditioning.

Sabine Gerull, MD, Joerg Halter, Christoph Bucher, Dominik Heim, MD, André Tichelli, MD, Alois Gratwohl, MD, Martin Stern, MD

Blood (2009) 114 (22): 3337.

https://doi.org/10.1182/blood.V114.22.3337.3337

Published: 2009

Journal Articles

Cyclophosphamide-Busulfan Instead of Busulfan-Cyclophosphamide for Conditioning in Allogeneic Hematopoietic Stem Cell Transplantation.

Nathan Cantoni, Sabine Gerull, Dominik Heim, Joerg Halter, Dimitrios Tsakiris, Christoph Bucher, Alicia Rovo, Caroline Arber, Andreas S. Buser, Jakob R. Passweg, Andre Tichelli, Martin Stern, Alois Gratwohl

Blood (2009) 114 (22): 2268.

https://doi.org/10.1182/blood.V114.22.2268.2268

Published: 2009

Journal Articles

Long-term polyclonal and multilineage engraftment of methylguanine methyltransferase P140K gene-modified dog hematopoietic cells in primary and secondary recipients

Brian C. Beard, Reeteka Sud, Kirsten A. Keyser, Christina Ironside, Tobias Neff, Sabine Gerull, Grant D. Trobridge, Hans-Peter Kiem

Blood (2009) 113 (21): 5094–5103.

https://doi.org/10.1182/blood-2008-09-176412

Published: 2009

Includes: Supplemental data

Journal Articles

Sustained Stable Engraftment of MGMT Gene-Modified Long-Term Repopulating Cells in Primary and Secondary Canine Recipients.

Brian C. Beard, PhD, Reeteka Sud, PhD, Sabine Gerull, MD, Laura J. Peterson, BS, Tobias Neff, MD, Hans-Peter Kiem, MD

Blood (2006) 108 (11): 202.

https://doi.org/10.1182/blood.V108.11.202.202

Published: 2006

Journal Articles

Polychemotherapy in Combination with Thalidomide Followed by Autologous or Allogeneic Transplantation for Rescue after Autograft or Induction Therapy Failure in Patients with Multiple Myeloma.

Ute Hegenbart, MD, Stefan O. Schonland, MD, Thomas Moehler, MD, Axel Benner, PhD, Sabine Gerull, MD, Martin Goerner, MD, Hans-Joerg Schaefer, MD, Gerlinde Egerer, MD, Peter Dreger, MD, Anthony D. Ho, MD, Hartmut Goldschmidt, MD

Blood (2006) 108 (11): 3018.

https://doi.org/10.1182/blood.V108.11.3018.3018

Published: 2006

Journal Articles

Recovery of Polyclonal Immunoglobulin Synthesis after Autologous Stem Cell Transplantation in Multiple Myeloma Patients as a Prognostic Factor for Event-Free Survival.

Annette Höfer, Axel Benner, Jens Klaus, Iris Breitkreutz, Doris Herrmann, Friedrich W. Cremer, Sabine Gerull, Thomas Moehler, Gerlinde Egerer, Ute Hegenbart, Anthony D. Ho, Hartmut Goldschmidt

Blood (2004) 104 (11): 939.

https://doi.org/10.1182/blood.V104.11.939.939

Published: 2004

Journal Articles

Non-Myeloablative Allogeneic Transplantation in Patients with Relapsed or Refractory Multiple Myeloma.

Sabine Gerull, MD, Ute Hegenbart, MD, Martin Goerner, MD, Axel Benner, Thomas Moehler, MD, Hartmut Goldschmidt, MD, Anthony D. Ho, MD

Blood (2004) 104 (11): 2759.

https://doi.org/10.1182/blood.V104.11.2759.2759

Published: 2004

NARROW

Therapy Management and Outcomes in Newly Diagnosed Unfit AML Patients Receiving Venetoclax + HMA - Insights from a Prospective Real-World Study in Switzerland and Austria

A National Platform and Scoring System Allocates CAR-T Treatment Slots for Multiple Myeloma to Patients with High Likelihood of Complete Remission

Impact of Amotosalen/UVA Pathogen Inactivated Platelet Components on Outcomes after Allogeneic Hematopoetic Stem Cell Transplantation: A Single Center Analysis

Red Blood Cell Allo-Antibodies after Allogeneic Hematopoietic Stem Cell Transplantation

Evaluation Of The Pre-Transplantation Workup Before Allogeneic Transplantation and Reasons For Delaying Or Cancelling Transplant

Allogeneic Transplantation for Multiple Myeloma – the Swiss Experience

Prognostic Impact of Different Iron Parameters In Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Cyclosporine Levels and Rate of Graft Rejection Following Reduced Intensity Conditioning.

Cyclophosphamide-Busulfan Instead of Busulfan-Cyclophosphamide for Conditioning in Allogeneic Hematopoietic Stem Cell Transplantation.

Long-term polyclonal and multilineage engraftment of methylguanine methyltransferase P140K gene-modified dog hematopoietic cells in primary and secondary recipients

Sustained Stable Engraftment of MGMT Gene-Modified Long-Term Repopulating Cells in Primary and Secondary Canine Recipients.

Polychemotherapy in Combination with Thalidomide Followed by Autologous or Allogeneic Transplantation for Rescue after Autograft or Induction Therapy Failure in Patients with Multiple Myeloma.

Recovery of Polyclonal Immunoglobulin Synthesis after Autologous Stem Cell Transplantation in Multiple Myeloma Patients as a Prognostic Factor for Event-Free Survival.

Non-Myeloablative Allogeneic Transplantation in Patients with Relapsed or Refractory Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only